Trevena, Inc. Announces Proposed Underwritten Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Tech selloff weighs down Wall Street as bond yields climb
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Trevena (TRVN) Prices 6.5M Common Stock Offering at $9.75/Share
September 11, 2015 9:01 AM EDTTrevena (NASDAQ: TRVN) announced the pricing of an underwritten offering of 6,500,000 shares of its common stock, offered at a price to the public of $9.75 per share. All of the shares of common stock to be sold in the offering are to be sold... More
Trevena (TRVN) to Sell Common Stock in Underwritten Offering
September 10, 2015 4:14 PM EDTTrevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company, today announced its intention to offer and sell shares of its common stock in an underwritten offering pursuant to an existing shelf registration statement. All of the shares in the proposed offering are... More
